24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
85.23% |
|
CANCER |
5.37% |
|
ENZYME DYNAMICS |
4.7% |
|
EBOLA |
2.91% |
|
PEPTIDOMIMETIC CD40L BINDING |
.89% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
.89% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
86.99% |
|
EBOLA |
3.33% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
2.75% |
|
CANCER |
2.5% |
|
ENZYME DYNAMICS |
2.17% |
|
PEPTIDOMIMETIC CD40L BINDING |
1.49% |
|
GRASPETIDE RING FORMATION |
.47% |
|
SUCROSE TRANSPORTER ATSUC1 |
.29% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
68.91% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
5.44% |
|
ENZYME DYNAMICS |
5.35% |
|
CANCER |
3.82% |
|
ATSTP10 SUCROSE TRANSPORT |
3.74% |
|
EBOLA |
3.5% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
2.54% |
|
RCA TEMPERATURE SIMULATIONS |
2.38% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
1.85% |
|
PEPTIDOMIMETIC CD40L BINDING |
1.24% |
|
ATSTP10 TRANSPORT SIMULATION |
.75% |
|
GRASPETIDE RING FORMATION |
.16% |
|
ATWRI1 MUTANT SCREENING |
.09% |
|
MEMBRANE TRANSPORT |
.08% |
|
NIPAH VIRUS DECOY PROTEIN DYNAMICS |
.08% |
|
SUCROSE TRANSPORTER ATSUC1 |
.07% |